Company Overview - NEXGEL, Inc. is a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications [3] - The company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades [3] - NEXGEL's product brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George [3] - The company has strategic contract manufacturing relationships with leading consumer healthcare companies [3] Financial Results Announcement - NEXGEL will report its financial results for the first quarter of 2025 after the market close on May 13, 2025 [1] - A conference call will be hosted by the company at 4:30 P.M. ET on the same day to discuss the financial results [1][2] - For those unable to join the live call, a replay will be available until May 27, 2025, with specific dial-in numbers provided [2]

Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma ...

First Quarter 2025 May 2025 Earnings Supplement Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward- looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, estimates of our total addressable market, our abi ...

Core Insights - AMN Healthcare Services reported a revenue of $689.53 million for the quarter ended March 2025, reflecting a 16% decline year-over-year, while EPS was $0.45 compared to $0.97 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $671.3 million by 2.72%, and the EPS surpassed the consensus estimate of $0.19 by 136.84% [1] Financial Performance Metrics - AMN Healthcare's stock has returned -5.3% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change, and currently holds a Zacks Rank 3 (Hold) [3] - In the Physician and leadership solutions segment, Days Filled were reported at 51.34 million, slightly below the average estimate of 51.95 million, while revenue per day filled was $2.74 million, exceeding the estimated $2.63 million [4] - Revenue from Physician and leadership solutions was $174.07 million, surpassing the average estimate of $171.10 million, but showing a year-over-year decline of 7.8% [4] - Revenue from Nurse and allied solutions was $413.26 million, exceeding the average estimate of $397.20 million, but reflecting a significant year-over-year decline of 20.4% [4] - Revenue from Technology and workforce solutions was $102.21 million, slightly below the estimated $103 million, marking a 9.4% decrease compared to the year-ago quarter [4] - Segment operating income for Nurse and allied solutions was $32.24 million, above the estimated $30.79 million, while for Technology and workforce solutions it was $35.25 million, below the estimated $37.97 million [4] - Segment operating income for Physician and leadership solutions was $14.46 million, falling short of the estimated $17.29 million [4]

Astrana Health (ASTH) Q1 2025 Earnings Call May 08, 2025 05:30 PM ET Company Participants Brandon Sim - President & CEOChan Basho - CFO & COORyan Daniels - Group Head–Healthcare Technology and ServicesJack Slevin - VP - Healthcare Services Equity ResearchJailendra Singh - Managing DirectorDavid Larsen - Managing DirectorZach Haggerty - Equity Research AssociateThomas Walsh - Equity Research Associate Conference Call Participants Michael Ha - Senior Research AnalystRyan Langston - Director & Senior Analyst - ...

Financial Data and Key Metrics Changes - The company reported first quarter revenue of $690 million, exceeding the high end of guidance by $10 million, primarily driven by strong performance in labor disruption, locum tenants, and allied businesses [6][18] - Adjusted EBITDA for the first quarter was $64 million, down 34% year over year and 15% sequentially, with an adjusted EBITDA margin of 9.3% [26] - The first quarter net loss was $1 million, compared to net income of $17 million in the prior year period [26] Business Line Data and Key Metrics Changes - Nurse and Allied Solutions revenue was $413 million, down 20% year over year, primarily due to lower volume and rates [19][20] - Travel nurse revenue decreased to $215 million, a 36% decline from the prior year [20] - Physician and Leadership Solutions segment revenue was $174 million, an 8% decrease year over year, with locum tenants revenue at $141 million, down 3% year over year [21][22] Market Data and Key Metrics Changes - The company experienced a 16% year-over-year decline in consolidated revenue, with a 6% sequential decrease [18] - Consolidated gross margin was 28.7%, slightly above guidance but down 270 basis points year over year [18][26] - Language services revenue increased by 5% year over year, while VMS revenue decreased by 33% year over year [25] Company Strategy and Development Direction - The company is focusing on enhancing its technology and automation capabilities to improve service delivery and operational efficiency [11][106] - AMN Healthcare is investing in AI tools to enhance recruiter productivity and improve service delivery [11][106] - The company aims to maintain operating leverage superior to competitors while generating cash flow for business investments and debt reduction [13] Management's Comments on Operating Environment and Future Outlook - Management noted that demand has not fully recovered to pre-pandemic levels in several business areas, including travel nursing and interim leadership [15] - The company is seeing heightened competition in language services, but believes it holds a distinct advantage due to high-quality solutions [16] - Management expressed confidence in the company's ability to support clients effectively while maintaining service quality [61] Other Important Information - The company generated $93 million in operating cash flow in the first quarter, reducing its revolving credit balance by $60 million [14][27] - The company has received industry recognition for innovation, including the 2025 Innovators Award from Modern Healthcare [14] Q&A Session Summary Question: Can you talk about the VMS and MSP wins? - Management indicated that recent wins reflect a strategy to broaden market positioning and are characterized as small to medium wins, with competitive nature [35][36] Question: What is the outlook for language services? - Management expects continued healthy growth in language services despite competitive pressures and recent consolidation in the space [39][40] Question: Are bill rates stabilizing in the travel nurse segment? - Management noted stabilization in bill rates and indicated that unfilled orders are at similar levels as before, suggesting a potential for future increases [45][46] Question: What are the capital allocation priorities? - The company prioritizes using free cash flow to pay down debt while continuing to invest in innovation and technology [90][92] Question: How is the international business expected to progress? - Management anticipates stabilization in the international business with expectations of positive growth in 2026 as visa dates move forward [83][85]

Performant Financial (PFMT) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Jon Bozzuto - Head - Investor RelationsSimeon Kohl - CEORohit Ramchandani - Chief Financial Officer Conference Call Participants Anderson Schock - Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the Performant Healthcare Inc. First Quarter twenty twenty five Earnings Conference Call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a quest ...

Financial Data and Key Metrics Changes - Consolidated revenue for Q1 2025 was $690 million, exceeding the high end of guidance by $10 million, driven by strong performance in labor disruption, locum tenants, and allied businesses [6][19] - Adjusted EBITDA for Q1 2025 was $64 million, down 34% year over year and 15% sequentially, with an adjusted EBITDA margin of 9.3% [26][27] - Consolidated gross margin was 28.7%, slightly above guidance but down 270 basis points year over year and 110 basis points sequentially [19][10] - The company reported a net loss of $1 million for Q1 2025, compared to net income of $17 million in the prior year [26][27] Business Line Data and Key Metrics Changes - Nurse and Allied Solutions revenue was $413 million, down 20% year over year, primarily due to lower volume and rates [20][21] - Travel nurse revenue decreased by 36% year over year to $215 million, while allied revenue was $147 million, down 13% year over year [21][22] - Physician and Leadership Solutions segment revenue was $174 million, an 8% decrease year over year, with locum tenants revenue at $141 million, down 3% year over year [22][23] - Technology and Workforce Solutions revenue was $102 million, down 9% year over year, with language services revenue increasing by 5% year over year to $75 million [24][25] Market Data and Key Metrics Changes - Demand for allied business grew mid-teens year over year, with bookings for the next school year trending towards growth [8][9] - The company noted heightened competition in language services, with industry consolidation leading to price competition [16][41] - The travel nurse market is experiencing intense competition, with some orders priced at levels that are not being filled [9][15] Company Strategy and Development Direction - The company is focused on enhancing technology and automation to improve service delivery and operational efficiency, including the rollout of new tools for recruiters [11][105] - AMN is investing in AI tools to reduce costs and improve service delivery, with a focus on maintaining high-quality service [11][105] - The company aims to leverage its diversified solutions to maintain operating leverage superior to competitors and generate cash flow for business investment [13][92] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to support clients amid ongoing labor disruption, emphasizing the importance of technology and automation [17][61] - The company anticipates continued demand growth in healthcare, despite some segments not recovering to pre-pandemic levels [15][81] - Management acknowledged a slowdown in client decision-making but noted strong demand across various business lines [94][82] Other Important Information - The company received industry recognition for innovation, being named one of the 15 innovative healthcare organizations by Modern Healthcare [14] - AMN continues to focus on debt reduction, with a net leverage ratio of 3.1 times [28][90] Q&A Session Summary Question: Can you talk about the VMS and MSP wins? - Management indicated that recent wins are small to medium in size but carry significant weight, reflecting a strategy to broaden market positioning [36][37] Question: What is the outlook for language services? - Management expects healthy growth in language services, despite competitive pressures and some margin decline [40][41] Question: Are bill rates stabilizing in the travel nurse segment? - Management noted stabilization in bill rates, with a premium spread of contingent costs to permanent labor at about 11% [46][47] Question: What is the impact of labor disruption on revenue? - Management stated that the increase in labor disruption revenue is due to improved internal focus and technology, with a stronger pipeline of opportunities [60][61] Question: How is the international business progressing? - Management expects stabilization in the international business, with a positive outlook for 2026 as visa dates move forward [83][85] Question: What are the capital allocation priorities? - The company prioritizes debt reduction while continuing to invest in innovation and technology [89][90]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $650.7 million, down 5% year over year and 2% sequentially, primarily due to known NEMT contract attrition, lower build hours in PCS, and membership churn in monitoring [20][21] - Net loss for the quarter was $50.4 million, up from $22.3 million a year ago, mainly due to higher interest expense which rose to $38.8 million [21] - Adjusted net loss was $24.5 million or negative $1.71 per share, reflecting the exclusion of restructuring-related costs and amortization of intangibles [21] - Adjusted EBITDA was $32.6 million, essentially flat year over year but down sequentially, with key drivers including an $8 million impact from net NEMT contract development [21][22] Business Line Data and Key Metrics Changes - In NEMT, revenue was $449 million, representing 69% of total revenue, declining 6% year over year due to previously disclosed contract losses [22] - Average monthly members in NEMT declined 19% year over year and 20% sequentially, while utilization from the normalization of healthcare increased to 12% [22] - PCS contributed $181.8 million in revenue or 28% of total revenue, with revenue per hour rising 1.1% while service hours declined 2.1% due to expected seasonality [24] - Monitoring contributed $18.1 million in revenue, representing just 3% of total revenue but 16% of total adjusted EBITDA, with adjusted EBITDA at $5.2 million for a 29% segment margin [25] Market Data and Key Metrics Changes - The broader opportunity in the 2026 pipeline exceeds $500 million in potential contract value, with the company experiencing a loss of a regional contract totaling $15 million in annual revenue [6][7] - In Indiana, referral volume increased by more than 45% year over year, while new Southeastern markets delivered sequential growth [9] Company Strategy and Development Direction - The company aims to grow and retain core customer relationships, digitize and automate the Care Access platform, optimize the operating model for simplicity and scale, increase capital efficiency, and deliver high-impact client-centric supportive care [4][5] - The long-term vision is to become the digital infrastructure for supportive care, unifying fragmented benefits and delivering a coordinated member experience [19] Management's Comments on Operating Environment and Future Outlook - Management noted that the decline in revenue was expected and reflects prior year customer transitions and market dynamics that are largely behind the company [20] - The company is focused on executing against measurable initiatives and communicating progress through clear objective KPIs and milestones, without issuing formal guidance for 2025 [28] Other Important Information - The company launched a company-wide G&A reduction initiative targeting approximately $25 million in annualized savings [14] - The net contracts receivable rose to $109 million, up from $95 million in Q4, due to expected billing timing [26] Q&A Session Summary Question: How should cash flow generation be modeled for the rest of the year? - Management indicated that EBITDA is driving cash flow and expects meaningful improvement in cash flow generation as the year progresses, particularly due to contract restructuring and working capital improvements [31][38] Question: Why did contract receivables increase despite a decline in revenue? - The increase in accounts receivable was attributed to the contract mix and shared risk contracts that have not yet been converted [39][40] Question: Is there a positive cash flow possibility in Q3? - Management acknowledged that due to large debt payments in Q2 and Q4, positive cash flow from operations may not be achievable in those quarters, but they feel good about cash flow generation for the year overall [51][54] Question: Can you elaborate on the G&A savings? - The $25 million in G&A savings primarily comes from labor efficiencies within corporate and shared service areas as the company continues to streamline operations [57][59]

Financial Data and Key Metrics Changes - Total revenue for Q1 2025 was $59.2 million, down 7% year over year, but above the high end of guidance [5][21] - Adjusted EBITDA was $14.7 million, representing a 25% margin, which was well ahead of expectations [6][21] - Unlevered free cash flow for the trailing twelve months was $67.1 million, down 12% year over year, with a 91% conversion from adjusted EBITDA [27][28] Business Line Data and Key Metrics Changes - Subscription revenue declined 7% year over year, while Professional Services revenue grew 9% in the quarter [23] - Adjusted gross profit was $47.1 million, down 11% from Q1 2024, with a gross profit margin of 79.5% [23] - Adjusted operating income was $12 million, down 35% from Q1 2024, with an operating income margin of 20% [26] Market Data and Key Metrics Changes - New logo activity was solid across all end markets, indicating ongoing demand for differentiated actionable data [7] - Renewal rates stabilized in Q1 at levels observed in the second half of 2024, but retention rates remain lower than desired [7][8] Company Strategy and Development Direction - The company is focusing on four strategic pillars: differentiated data, seamless integration, customer success, and digital engagement [9][18] - There is a commitment to improving retention rates and enhancing the value proposition through targeted investments in data quality and customer engagement [18][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in operational strategies despite lower retention rates, indicating a lag in seeing the positive impacts of changes made [8][19] - The company remains on track to meet full-year financial targets, with expectations for sequential revenue growth in the near term [19][33] Other Important Information - The company experienced a goodwill impairment of $176.5 million due to stock price decline, which is a non-cash accounting charge [29] - The company repurchased approximately 5.6 million shares for a total of $21.2 million, leaving $77 million remaining under the existing authorization [28] Q&A Session Summary Question: Can you elaborate on data integrations and challenges? - Management indicated that data sharing and integration depend on various factors, including data security and system compatibility, and they are working to facilitate these integrations [36][40] Question: What is the agency strategy and its impact on the go-to-market motion? - The agency strategy is seen as a logical next step to help customers activate data, applicable across all customer segments, with expectations for contributions this year [41][43] Question: What is the expected timeframe for seeing growth inflection? - Management anticipates seeing improvements in growth rates within the year as operational changes take effect [46][48] Question: How does the company plan to win back customers? - The company believes that high-quality data and service will create a competitive advantage, allowing them to win back former customers while also acquiring new ones [49][50] Question: What is the churn rate and competitive environment? - Churn rates were consistent with the second half of the previous year, and while there are pressures in the market, management has not observed significant changes in competitive dynamics [77][78]